#aduhelm
Live, measured metrics for the hashtag #aduhelm from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #aduhelm
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mastodon.online (Mastodon public tags API) · fetched 2026-09-27 02:32 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · mastodon.online (Mastodon public search API) · fetched 2026-09-27 02:32 UTCLive pulse
measured · mastodon.online (Mastodon tag timeline) · fetched 2026-09-27 02:32 UTCEverything below is measured over the latest 20 public posts (spanning ~43973 hours).
Posting hours (UTC) — busiest: 08:00
Languages: English (19) · Finnish (1)
Avg boosts / post: 1
Top of the latest posts
"Biogen was prepared to spend up to several billion dollars — more than two-and-a-half times what it spent developing the drug — on aggressive marketing to counter expected 'pushback' over whether Aduhelm was worth its price." Damning artic
This Is The Most Commonly Missed Warning Sign Of Dementia Neurologists reveal the biggest early symptom of the disease and what you can do about it. https://www.huffpost.com/entry/signs-dementia-symptoms-goog_l_6a2acdc1e4b0a99062fc1028 #Top
@Lupposofi A couple of years ago, I coauthored a paper trying to measure the applicability of the #aducanumab (#Aduhelm)'s results applied to the real world practice of a #geriatric outpatient clinic (with special focus on older persons wit
What “aduhelm” means
WikipediaAducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. It was developed by Biogen and Eisai. Aducanumab is given via intravenous infusion.
“Aducanumab” on Wikipedia (CC BY-SA) →#aduhelm across platforms
every network with a public tag surfaceFollow #aduhelm straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/aduhelm